156 related articles for article (PubMed ID: 32845764)
1. Improving guideline-mandated care of patients with implantable cardiac defibrillators.
Garner D; Blackburn M; Wright DJ; Rao A
Br J Hosp Med (Lond); 2020 Aug; 81(8):1-10. PubMed ID: 32845764
[TBL] [Abstract][Full Text] [Related]
2. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses.
Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A
Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003
[TBL] [Abstract][Full Text] [Related]
3. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
Daeschler M; Verdino RJ; Kirkpatrick JN
Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
5. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
[TBL] [Abstract][Full Text] [Related]
7. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
Herman M; Horner K; Ly J; Vayl Y
J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
[TBL] [Abstract][Full Text] [Related]
8. Discussing deactivation of implantable cardiac defibrillators.
Bahl R; Dubrey S
Br J Hosp Med (Lond); 2020 Aug; 81(8):1-5. PubMed ID: 32845751
[TBL] [Abstract][Full Text] [Related]
9. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
[TBL] [Abstract][Full Text] [Related]
10. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
Gura MT
AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
[TBL] [Abstract][Full Text] [Related]
12. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
Russo JE
Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
[TBL] [Abstract][Full Text] [Related]
13. Features and outcomes of patients who underwent cardiac device deactivation.
Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Hayes DL; Mueller PS
JAMA Intern Med; 2014 Jan; 174(1):80-5. PubMed ID: 24276835
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter defibrillator deactivation: a hospice quality improvement initiative.
Kraynik SE; Casarett DJ; Corcoran AM
J Pain Symptom Manage; 2014 Sep; 48(3):471-7. PubMed ID: 24480530
[TBL] [Abstract][Full Text] [Related]
15. Quality of death: implantable cardioverter defibrillators and proactive care.
Sears SF; Sowell LV; Kuhl EA; Handberg EM; Kron J; Aranda JM; Conti JB
Pacing Clin Electrophysiol; 2006 Jun; 29(6):637-42. PubMed ID: 16784431
[TBL] [Abstract][Full Text] [Related]
16. Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.
Niewald A; Broxterman J; Rosell T; Rigler S
J Med Ethics; 2013 Feb; 39(2):94-7. PubMed ID: 23139392
[TBL] [Abstract][Full Text] [Related]
17. Quality dying: An approach to ICD deactivation in the hospital setting.
Turner S; Torabi S; Stilos K
Am J Hosp Palliat Care; 2020 Sep; 37(9):664-668. PubMed ID: 32126793
[TBL] [Abstract][Full Text] [Related]
18. Improving implantable cardioverter defibrillator deactivation discussions in admitted patients made DNR and comfort care.
Choi DY; Wagner MP; Yum B; Jannat-Khah DP; Mazique DC; Crossman DJ; Lee JI
BMJ Open Qual; 2019; 8(4):e000730. PubMed ID: 31922034
[TBL] [Abstract][Full Text] [Related]
19. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?
Raphael CE; Koa-Wing M; Stain N; Wright I; Francis DP; Kanagaratnam P
Pacing Clin Electrophysiol; 2011 Dec; 34(12):1628-33. PubMed ID: 21955046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
